articles for penn medicine cancer news

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient’s immune system – a weakness that in...

http://www.upenn.edu/pennnews/news/t-cells-recognize-her2-receptor-may-be-key-preventing-her2-breast-cancer-recurrence-penn-study-